REFILE-Petco keeps annual outlook unchanged after muted sales in Q1
Petco Health and Wellness WOOF | 0.00 |
Corrects to remove repeated period from headline
Overview
U.S. pet retailer's Q1 revenue slightly beat analyst expectations, rising 0.2% yr/yr
Comparable sales returned to positive growth, up 0.7% yr/yr
Company reaffirmed full-year 2026 outlook and provided Q2 guidance
Outlook
Petco reaffirms FY 2026 net sales outlook of flat to up 1.5% y/y
Company expects FY 2026 adjusted EBITDA of $415 mln to $430 mln
Petco sees Q2 2026 net sales up about 0.3% y/y, adjusted EBITDA $110 mln to $112 mln
Result Drivers
CONSUMABLES IMPROVEMENT - Co said improvement in consumables business contributed to Q1 results
SERVICES OUTPERFORMANCE - Services business continued to outperform and was described as a key growth engine
OPERATIONAL IMPROVEMENTS - Co said operational and economic improvements are materializing, supporting positive comp sales
Company press release: ID:nPnTRPNxa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
Slight Beat* |
$1.50 bln |
$1.49 bln (9 Analysts) |
Q1 Comparable sales GROWTH |
|
0.7% |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."
Wall Street's median 12-month price target for Petco Health and Wellness Company Inc is $3.75, about 26.7% above its June 2 closing price of $2.96
The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
